Skip to main content

Search Results

Leukemia survivor and Honored Hero, Jelien, smiling with a Subaru blanket

Beyond Blankets: Subaru Loves to Care brings comfort and warmth

Blood cancer treatment can be a scary and confusing time. And blood cancer patients want to feel like they’re not alone. 

That’s why The Leukemia & Lymphoma Society (LLS) and Subaru are partnering to bring warmth and comfort to blood cancer patients through warm blankets, patient care kits, and handwritten notes of encouragement.

researchers

Two Prominent Themes of 2020 Make an Appearance at #ASH20: Covid-19 and Racial Disparities

With the COVID-19 pandemic driving yet another science conference to the virtual world, it is fitting that the 62nd ASH Annual Meeting and Exposition officially kicked off today with a virtual fireside chat via live stream featuring none other than Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, and a member of the administration’s coronavirus task force.

BURLINGTON STORES RAISES RECORD-BREAKING $5.1 MILLION FOR LLS

Burlington Stores and The Leukemia & Lymphoma Society (LLS) joined forces for the 17th consecutive year to help save lives and bring smiles to those touched by blood cancer. From September 9 through December 1, Burlington’s more than 670 locations nationwide encouraged customers to donate $1 or more at checkout to support LLS’s goal to create a world without blood cancer. This campaign, combined with Burlington’s corporate associate fundraising efforts, raised a record smashing $5.1 million for LLS, helping the organization fund lifesaving research and treatments.

Born with Leukemia, Eevie is now age 3 – and Cancer Free!

After Eevie was born, she was diagnosed with a rare form of childhood blood cancer that affects 1 in 5 million newborns. She was given a 17 percent chance of surviving to age 2. This month, Eevie celebrated her third birthday. Her mother, Brynne, tells her story…

People from three featured stories: Charlie, Ken, and Chloe

A Source of Hope: Understanding Bone Marrow and Stem Cell Transplants

Imagine a community filled with families, friends, and healthcare professionals united to transform the meaning of living with blood cancer. This diverse group of people—including researchers, doctors, care partners, and healthcare teams—are bound together by hope, resilience, and a shared goal: to overcome the challenges and live longer better lives.

Hiker looking at mountain

Helping Survivors Lead Longer Better Lives

Late last year I had the privilege of attending a special screening of the documentary American Symphony. The film chronicles the experiences of writer Suleika Jaouad and her husband musician Jon Batiste after learning that her acute myeloid leukemia (AML) had returned after years of remission. The movie shows how the couple navigates uncertainty, treatment, and their new normal afterwards. 

Cancer Won’t Stop Coach Marie

Thousands of runners will hit the streets of Chicago this weekend for the 2016 Chicago Marathon. Before they cross the start and finish lines, they will go through an intense training program to meet one of their most challenging goals: 26.2 miles.

As a coach for The Leukemia & Lymphoma Society’s Team In Training (TNT), Marie Jarrell of Chicago is the inspiring drumbeat for hundreds of Chicago marathon trainees every year, leading them down the path to fitness and providing them with inspiration along the way.

Powerful Partnerships are Helping to Save Lives

The Leukemia & Lymphoma Society (LLS) has helped millions impacted by cancer throughout their almost 70-year history. But the fight against blood cancers cannot be won without support.

2018 Nobel Prize in Physiology or Medicine: Unleashing the Immune System

The Nobel Prize in Physiology or Medicine has been awarded today to two scientists whose groundbreaking work led to the development of a class of immunotherapies called checkpoint inhibitors that work by releasing the brakes on the immune system.

HIGH SCHOOL STUDENTS 'TEST' THE LIMITS OF PHILANTHROPY

For the second year in a row, high school students across the country are redefining what it means to be philanthropic in today’s youth culture. Through The Leukemia & Lymphoma Society’s (LLS) newest innovation in fundraising, Students of the Year, more than 600 motivated high school students raised significant funds for LLS’s cutting-edge cancer research and patient services.

Fredia with her Team In Training team, Kristen's Klimbers

4 Perspectives on How Nonprofits Help

If you want to change the world, there’s more than one way to do it. You could start in your community, helping friends and neighbors. You could also turn to a nonprofit organization—as a volunteer, donor, advocate, or even by joining the staff—to widen your impact.  

We know a lot of changemakers at The Leukemia & Lymphoma Society (LLS). Passionate, amazing people who work hard to help us make life better for blood cancer patients, survivors, and their families. They know that we can make the most progress toward a world without blood cancer together.  

#ASCO20: Cancer in the Time of COVID-19, and Progress in Myeloma and Lymphoma

As National Cancer Research Month (May) winds down, it seems timely to reflect on progress in cancer treatments. And that is precisely what we will do this weekend.

A Special Surprise for Pediatric Cancer Patient Counting Down the Days until Treatment Ends

"A Style for Every Smile” Campaign is Brightening the Faces of Pediatric Cancer Patients like 4-Year-Old Sasha Nationwide

At the tender age of four, Sasha has endured more than most of us will in a lifetime. In October 2017, at just two years old, she was diagnosed with acute lymphoblastic leukemia, a diagnosis no parent wants to hear.

"It sounds so stereotypical, but I just didn't believe it. I was completely in denial,” says Sasha’s mom, Randi.

Achieving the Impossible: What’s ahead in 2018?

We’ve just concluded one of the most historic years on record in terms of new therapy approvals for blood cancers. In all, the U.S. Food and Drug Administration (FDA) approved 18 therapies to treat patients with blood cancers, including some entirely new agents and some new uses for already approved drugs.

Supporting development of RNA-targeting molecules for blood cancers

In June 2023, LLS made an equity investment in Rgenta Therapeutics to "Support development of RNA-targeting molecules for blood cancers."  Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Rgenta has a proprietary platform to mine the massive genomics data to identify targetable RNA processing events and to design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. 

LLS and Burlington Stores: Spreading Smiles Across the Country

For 16 years, Burlington Stores has partnered with The Leukemia & Lymphoma Society (LLS), funding research and lifesaving treatments. Together, they have saved lives and helped bring smiles to those touched by blood cancers, with more than $32 million raised to date. However, with nearly 1.3 million people in the U.S. living with or in remission from blood cancers, there is still more work to be done.

Accelerating Care and Cures for Children

Kaitlyn's Story

Eight-year-old Kaitlyn Johnson has had to deal with cancer for the majority of her young life. In fact, she was only 18 months old when she was diagnosed with acute lymphoblastic leukemia (ALL), the most common cancer among children and young adults. Her young life was quickly consumed with cancer treatments, doctors’ visits, and hospital stays. Throughout this time, Kaitlyn was brave, positive and continued to pursue her passion for dancing – no matter the location.

Childhood and Adolescent Blood Cancer Facts and Statistics

Childhood and Adolescent Blood Cancers
  •  An estimated 54,868 children and adolescents younger than 20 years in the US are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS) or myeloproliferative neoplasms (MPNs).
  • Leukemia is the most common cancer diagnosed in children and adolescents younger than 20 years and accounts for 25.4 percent of all cancer cases in this age-group.
  • From 2016 to 2020, the most recent 5 years for which data are available, leukemia and lymphoma accounted for 38.4 percent of all cancer types in